CSIMarket
 


Biomerica Inc   (BMRA)
Other Ticker:  
 

Biomerica Inc 's Tangible Leverage Ratio

BMRA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In Spite of the repayements of liabilities of -0.12%, in II Quarter 2023 ,Tangible Leverage Ratio deteriorated to 0.27, below the Biomerica Inc 's average Tangible Leverage Ratio.

Within In Vitro & In Vivo Diagnostic Substances industry Biomerica Inc achieved the lowest Tangible Leverage Ratio in the second quarter 2023. While Tangible Leverage Ratio total ranking has improved so far in the second quarter 2023 to 20, from total ranking in the first quarter 2023 at 602 .

Explain Tangible Leverage Ratio?
What is BMRA Market Share?
What are BMRA´s Total Liabilities?


BMRA Tangible Leverage Ratio (Nov 30 2023)
II. Quarter
(Aug 31 2023)
I. Quarter
(May 31 2023)
IV. Quarter
(Feb 28 2023)
III. Quarter
(Nov 30 2022)
II. Quarter
Y / Y Tangible Equity Change 29.55 % 29.47 % 41.74 % -37.78 % -16.76 %
Y / Y Total Liabilities Change -8.13 % -10.17 % -10.48 % -71.5 % -54.9 %
Tangible Leverage Ratio MRQ 0.27 0.23 0.24 0.38 0.38
BMRA's Total Ranking # 20 # 602 # 604 # 873 # 714
Seq. Tangible Equity Change -13.13 % -8.59 % 98.22 % -17.69 % -13.18 %
Seq. Total Liabilities Change -0.12 % -10.22 % 22.75 % -16.53 % -2.34 %



Tangible Leverage Ratio second quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 3
Overall Market # 20


Tangible Leverage Ratio Statistics
High Average Low
4.35 0.57 0.12
(May 31 2015)   (Aug 31 2016)




Financial Statements
Biomerica Inc 's Tangible Equity $ 9 Millions Visit BMRA's Balance sheet
Biomerica Inc 's Total Liabilities $ 2 Millions Visit BMRA's Balance sheet
Source of BMRA's Sales Visit BMRA's Sales by Geography


Cumulative Biomerica Inc 's Tangible Leverage Ratio

BMRA's Tangible Leverage Ratio for the trailling 12 Months

BMRA Tangible Leverage Ratio

(Nov 30 2023)
II. Quarter
(Aug 31 2023)
I. Quarter
(May 31 2023)
IV. Quarter
(Feb 28 2023)
III. Quarter
(Nov 30 2022)
II. Quarter
Y / Y Tangible Equity TTM Growth 29.55 % 29.47 % 41.74 % -37.78 % -16.76 %
Y / Y Total Liabilities TTM Growth -8.13 % -10.17 % -10.48 % -71.5 % -54.9 %
Tangible Leverage Ratio TTM 0.27 0.29 0.32 0.36 0.5
Total Ranking TTM # 15 # 4 # 516 # 4 # 468
Seq. Tangible Equity TTM Growth -13.13 % -8.59 % 98.22 % -17.69 % -13.18 %
Seq. Total Liabilities TTM Growth -0.12 % -10.22 % 22.75 % -16.53 % -2.34 %


On the trailing twelve months basis Due to repayements of liabilities of -0.12% Biomerica Inc decreased Tangible Leverage Ratio in the 12 months ending in II Quarter 2023 to 0.27, below the company's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the In Vitro & In Vivo Diagnostic Substances industry BMRA recorded the lowest Tangible Leverage Ratio. While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the II Quarter 2023, compared to the prior period, from 4 to 15.

Explain Tangible Leverage Ratio?
What is BMRA Market Share?
What are BMRA´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 3
Within the Market # 15


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
4.35 0.57 0.12
(May 31 2015)   (Aug 31 2016)




Companies with similar Tangible Leverage Ratio in the quarter ending Nov 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Tangible Leverage RatioNov 30 2023 MRQ Total LiabilitiesNov 30 2023 MRQ Tangible Equity
Biomerica Inc   0.27 $ 2.448  Millions$ 9.179  Millions
Celldex Therapeutics inc   0.09 $ 36.456  Millions$ 401.981  Millions

Date modified: 2024-02-17T22:12:44+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com